National HealthCare (NHC) Financials

$96.18 +1.81 (+1.92%)

As of 05/2/2025 04:10 PM Eastern

Annual Income Statements for National HealthCare

This table shows National HealthCare's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	45	46	51	56	59	68	42	139	22	67	102
Consolidated Net Income / (Loss)	53	53	51	56	59	68	42	139	20	65	102
Net Income / (Loss) Continuing Operations	53	53	51	56	59	68	42	139	20	65	102
Total Pre-Tax Income	85	85	80	75	75	88	52	150	27	89	136
Total Operating Income	68	67	61	54	56	49	48	51	32	57	86
Total Gross Profit	361	374	376	392	398	404	407	408	400	429	496
Total Revenue	872	907	924	964	980	996	1,028	1,074	1,086	1,142	1,307
Operating Revenue	829	865	878	917	933	948	979	1,029	1,041	1,088	1,261
Other Revenue	42	42	46	47	48	49	49	45	45	54	46
Total Cost of Revenue	510	533	548	572	583	593	621	666	686	712	811
Operating Cost of Revenue	510	533	548	572	583	593	621	666	686	712	811
Total Operating Expenses	293	307	315	338	342	355	359	357	368	372	411
Selling, General & Admin Expense	217	227	231	250	254	268	275	267	289	288	321
Depreciation Expense	34	37	39	43	42	42	42	41	40	42	42
Other Operating Expenses / (Income)	42	43	45	45	46	44	42	42	38	42	47
Total Other Income / (Expense), net	17	18	20	20	19	39	4.27	99	-4.67	32	51
Interest & Investment Income	-	-	-	-	-	1.98	-22	81	-16	15	31
Other Income / (Expense), net	17	18	20	20	19	37	27	18	11	17	20
Income Tax Expense	32	32	30	19	16	20	10	11	7.25	23	34
Net Income / (Loss) Attributable to Noncontrolling Interest	-	0.00	0.00	-0.52	-0.27	-0.24	0.12	0.50	-2.47	-1.51	0.16
Basic Earnings per Share	$3.24	$3.34	$3.34	$3.70	$3.87	$4.47	$2.74	$9.03	$1.46	$4.36	$6.62
Weighted Average Basic Shares Outstanding	13.82M	13.89M	15.13M	15.19M	15.22M	15.27M	15.31M	15.35M	15.41M	15.31M	15.39M
Diluted Earnings per Share	$3.14	$3.20	$3.32	$3.69	$3.87	$4.44	$2.72	$8.99	$1.45	$4.34	$6.53
Weighted Average Diluted Shares Outstanding	14.22M	14.49M	15.21M	15.22M	15.24M	15.36M	15.37M	15.42M	15.45M	15.38M	15.60M
Weighted Average Basic & Diluted Shares Outstanding	13.80M	13.90M	15.10M	15.20M	15.26M	15.33M	15.37M	15.45M	15.36M	15.35M	15.45M
Cash Dividends to Common per Share	$1.34	$1.54	$1.75	$1.89	$1.98	$2.06	$2.08	$2.11	$2.26	$2.34	$2.42

This table shows National HealthCare's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-2.43	6.35	12	16	10	28	26	27	43	6.08
Consolidated Net Income / (Loss)	-3.11	5.57	11	16	10	28	26	27	43	6.03
Net Income / (Loss) Continuing Operations	-3.11	5.57	11	16	10	28	26	27	43	6.03
Total Pre-Tax Income	-4.25	7.41	16	22	14	37	36	37	58	6.06
Total Operating Income	4.08	9.05	10	14	13	20	16	23	21	27
Total Gross Profit	98	97	102	107	106	114	114	121	127	135
Total Revenue	271	265	270	283	288	301	297	301	340	369
Operating Revenue	260	253	258	270	277	283	286	289	329	357
Other Revenue	11	12	12	13	11	18	11	11	12	12
Total Cost of Revenue	173	167	168	175	183	187	183	180	213	234
Operating Cost of Revenue	173	167	168	175	183	187	183	180	213	234
Total Operating Expenses	94	88	92	93	93	94	98	98	106	108
Selling, General & Admin Expense	73	71	71	73	72	71	77	78	83	83
Depreciation Expense	10	10	10	10	10	12	11	9.34	11	11
Other Operating Expenses / (Income)	10	6.59	10	9.99	10	11	10	11	13	14
Total Other Income / (Expense), net	-8.33	-1.64	5.71	8.35	1.00	17	20	14	37	-21
Interest & Investment Income	-11	-4.33	1.39	4.65	-3.09	12	14	9.12	33	-25
Other Income / (Expense), net	2.73	2.69	4.32	3.70	4.10	4.54	5.69	4.96	4.22	4.83
Income Tax Expense	-1.14	1.84	4.44	6.41	3.91	8.70	9.46	9.49	15	0.03
Net Income / (Loss) Attributable to Noncontrolling Interest	-0.68	-0.78	-0.44	-0.36	-0.27	-0.44	0.04	0.26	-0.09	-0.05
Basic Earnings per Share	($0.16)	$0.42	$0.76	$1.06	$0.68	$1.86	$1.71	$1.74	$2.78	$0.39
Weighted Average Basic Shares Outstanding	15.45M	15.41M	15.34M	15.30M	15.30M	15.31M	15.35M	15.39M	15.41M	15.39M
Diluted Earnings per Share	($0.16)	$0.41	$0.76	$1.06	$0.68	$1.84	$1.69	$1.73	$2.73	$0.38
Weighted Average Diluted Shares Outstanding	15.45M	15.45M	15.36M	15.32M	15.32M	15.38M	15.51M	15.56M	15.67M	15.60M
Weighted Average Basic & Diluted Shares Outstanding	15.34M	15.36M	15.32M	15.32M	15.32M	15.35M	15.40M	15.42M	15.44M	15.45M
Cash Dividends to Common per Share	$0.57	$0.57	$0.57	$0.59	$0.59	$0.59	$0.59	$0.61	$0.61	$0.61

This table details how cash moves in and out of National HealthCare's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	-15	-31	-18	36	-13	6.09	97	-39	-45	51	-29
Net Cash From Operating Activities	82	83	91	94	98	100	203	62	8.74	111	107
Net Cash From Continuing Operating Activities	82	83	91	94	98	100	203	62	8.74	111	107
Net Income / (Loss) Continuing Operations	53	53	51	56	59	68	42	139	20	65	102
Consolidated Net Income / (Loss)	53	53	51	56	59	68	42	139	20	65	102
Depreciation Expense	34	37	39	43	42	42	42	41	40	42	42
Non-Cash Adjustments To Reconcile Net Income	13	1.90	1.28	2.33	-0.16	-19	72	-106	-0.44	-19	-32
Changes in Operating Assets and Liabilities, net	-19	-8.80	0.04	-6.20	-2.00	9.00	47	-11	-51	23	-5.03
Net Cash From Investing Activities	-67	-73	-81	-9.56	-34	-14	-64	-66	-5.98	-18	-237
Net Cash From Continuing Investing Activities	-67	-73	-81	-9.56	-34	-14	-64	-66	-5.98	-18	-237
Purchase of Property, Plant & Equipment	-53	-58	-63	-32	-30	-26	-22	-39	-30	-28	-28
Acquisitions	-1.98	-0.67	0.00	0.00	-0.53	-16	-6.65	-29	0.00	-2.70	-214
Purchase of Investments	-62	-61	-49	-31	-14	-13	-85	-109	-34	-34	-49
Sale of Property, Plant & Equipment	-	-	0.00	0.00	4.30	0.00	6.75	-	4.18	0.00	2.10
Sale and/or Maturity of Investments	52	53	36	54	6.09	46	43	102	50	47	52
Other Investing Activities, net	-1.54	-5.68	-6.53	-0.45	0.00	-5.46	-0.43	8.84	3.88	-0.20	-0.01
Net Cash From Financing Activities	-30	-42	-27	-49	-77	-80	-42	-35	-48	-43	100
Net Cash From Continuing Financing Activities	-30	-42	-27	-49	-77	-80	-42	-35	-48	-43	100
Repayment of Debt	-2.44	-3.69	-3.28	-23	-45	-49	-50	-	0.00	0.00	-13
Repurchase of Common Equity	-7.00	0.00	-8.20	0.00	-0.87	-0.87	-0.05	-0.84	-9.90	-2.48	-14
Payment of Dividends	-27	-30	-26	-28	-30	-32	-29	-33	-34	-36	-36
Issuance of Debt	0.00	110	-	-	0.00	0.00	40	-	0.00	0.00	150
Issuance of Common Equity	7.43	11	11	3.74	2.87	2.35	1.76	3.44	2.11	0.31	14
Other Financing Activities, net	-0.75	1.99	-0.64	-1.10	-4.45	-0.62	-4.16	-4.88	-5.50	-4.82	-1.17
Cash Interest Paid	2.24	2.97	4.53	5.18	4.90	3.12	1.43	0.85	0.49	0.29	3.42
Cash Income Taxes Paid	37	29	28	24	9.18	21	17	23	8.77	15	18

This table details how cash moves in and out of National HealthCare's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	-19	2.67	-0.19	28	17	5.71	-4.84	44	-51	-18
Net Cash From Operating Activities	-1.98	12	14	39	32	26	9.65	51	34	13
Net Cash From Continuing Operating Activities	-1.98	12	14	39	32	26	9.65	51	34	13
Net Income / (Loss) Continuing Operations	-3.11	5.57	11	16	10	28	26	27	43	6.03
Consolidated Net Income / (Loss)	-3.11	5.57	11	16	10	28	26	27	43	6.03
Depreciation Expense	10	10	10	10	10	12	11	9.34	11	11
Non-Cash Adjustments To Reconcile Net Income	20	-8.77	-2.06	-4.89	3.28	-15	-5.70	-17	-31	22
Changes in Operating Assets and Liabilities, net	-29	4.65	-5.42	18	8.77	1.11	-21	32	12	-27
Net Cash From Investing Activities	-0.65	2.83	-1.43	-0.82	-5.14	-10	-2.42	1.43	-224	-12
Net Cash From Continuing Investing Activities	-0.65	2.83	-1.43	-0.82	-5.14	-10	-2.42	1.43	-224	-12
Purchase of Property, Plant & Equipment	-7.53	-5.64	-6.64	-6.15	-6.51	-8.60	-5.96	-7.83	-5.66	-8.16
Purchase of Investments	-3.82	-5.08	-10	-4.13	-7.36	-12	-10	-14	-9.35	-16
Sale and/or Maturity of Investments	7.30	12	15	13	8.53	11	12	23	5.11	12
Other Investing Activities, net	3.40	-2.48	0.00	-0.41	0.21	-0.00	2.12	-0.23	0.14	-2.03
Net Cash From Financing Activities	-17	-12	-13	-10	-9.82	-9.83	-12	-7.61	139	-19
Net Cash From Continuing Financing Activities	-17	-12	-13	-10	-9.82	-9.83	-12	-7.61	139	-19
Repayment of Debt	-	3.50	-	-	-	-	-	-	-	-10
Payment of Dividends	-8.83	-8.77	-8.75	-8.73	-9.04	-9.04	-9.05	-9.09	-8.02	-9.69
Issuance of Common Equity	0.16	0.83	0.00	0.01	0.25	0.05	8.41	2.83	2.23	0.80

This table presents National HealthCare's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	1,074	1,045	1,087	1,097	1,081	1,287	1,362	1,403	1,275	1,311	1,524
Total Current Assets	323	279	291	329	322	341	457	427	354	406	424
Cash & Equivalents	70	38	26	59	43	50	147	108	59	107	76
Restricted Cash	27	27	26	6.40	9.97	30	31	10	54	57	20
Short-Term Investments	133	116	138	160	159	152	176	196	124	117	175
Note & Lease Receivable	0.44	0.46	3.26	1.45	1.29	1.70	0.93	0.45	0.30	0.50	0.51
Accounts Receivable	79	84	83	87	97	93	90	96	100	109	135
Inventories, net	7.13	7.57	7.51	7.15	7.47	7.44	8.78	8.58	7.09	7.39	9.04
Prepaid Expenses	2.26	2.17	2.65	2.86	3.86	6.64	2.98	7.36	10	8.86	9.06
Plant, Property, & Equipment, net	515	536	560	549	535	535	520	521	507	493	684
Plant, Property & Equipment, gross	822	875	933	959	979	1,017	1,030	1,064	1,081	1,102	1,282
Accumulated Depreciation	307	339	374	409	444	482	510	543	575	608	597
Total Noncurrent Assets	237	230	237	218	224	410	385	456	415	411	416
Long-Term Investments	176	189	198	182	186	166	166	118	105	126	136
Goodwill	18	18	18	18	21	21	21	168	168	168	170
Intangible Assets	-	-	-	-	-	-	0.00	7.04	7.04	7.04	20
Other Noncurrent Operating Assets	8.79	8.45	5.24	4.87	5.60	208	184	161	133	109	88
Other Noncurrent Nonoperating Assets	3.63	2.31	2.13	1.91	1.71	1.73	1.74	1.73	1.08	1.17	1.23
Total Liabilities & Shareholders' Equity	1,074	1,045	1,087	1,097	1,081	1,287	1,362	1,403	1,275	1,311	1,524
Total Liabilities	340	414	418	393	346	508	564	495	398	400	541
Total Current Liabilities	184	151	151	155	158	195	281	263	198	214	235
Short-Term Debt	3.09	3.28	3.48	3.70	3.92	14	4.42	-	4.99	0.86	7.50
Accounts Payable	39	37	36	33	36	34	38	40	34	38	41
Accrued Expenses	60	65	66	67	68	70	86	107	73	84	93
Dividends Payable	7.00	6.00	6.82	7.30	7.62	7.97	7.99	8.49	8.75	9.05	9.42
Other Current Liabilities	39	39	39	44	43	69	94	108	78	83	84
Total Noncurrent Liabilities	156	264	267	238	189	313	283	232	200	186	306
Long-Term Debt	10	120	120	100	55	-	-	-	-	0.00	130
Asset Retirement Reserve & Litigation Obligation	79	71	65	66	67	66	69	67	71	73	73
Noncurrent Deferred & Payable Income Tax Liabilities	0.00	9.10	22	18	19	24	14	6.85	11	17	36
Other Noncurrent Operating Liabilities	30	30	26	25	23	207	189	158	117	96	69
Total Equity & Noncontrolling Interests	734	631	670	703	734	779	798	908	878	910	983
Total Preferred & Common Equity	734	631	670	703	733	779	795	903	874	909	980
Total Common Equity	564	631	670	703	733	779	795	903	874	909	980
Common Stock	155	210	212	216	220	223	227	232	227	228	233
Retained Earnings	344	368	392	419	516	553	563	669	657	688	752
Accumulated Other Comprehensive Income / (Loss)	65	53	66	68	-2.75	2.56	5.06	1.61	-9.53	-6.60	-4.72
Noncontrolling Interest	-	-	0.00	0.69	1.18	0.48	3.08	5.46	3.24	1.73	3.00

This table presents National HealthCare's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024
Total Assets	1,296	1,265	1,281	1,282	1,320	1,340	1,563
Total Current Assets	345	338	369	383	418	448	446
Cash & Equivalents	45	46	78	100	94	136	85
Restricted Cash	51	31	56	55	60	52	54
Short-Term Investments	132	142	115	110	124	134	165
Note & Lease Receivable	-	-	-	-	0.49	0.71	0.58
Accounts Receivable	99	103	101	103	126	109	129
Inventories, net	7.30	6.95	7.00	7.37	6.76	6.63	7.84
Prepaid Expenses	10	8.21	11	7.56	6.75	8.79	4.89
Plant, Property, & Equipment, net	511	503	502	498	489	487	686
Plant, Property & Equipment, gross	1,076	1,088	1,097	1,102	1,066	1,073	1,283
Accumulated Depreciation	565	585	595	604	577	586	597
Total Noncurrent Assets	440	424	410	401	413	405	431
Long-Term Investments	121	121	113	110	136	137	144
Goodwill	168	168	168	168	168	168	170
Intangible Assets	7.04	7.04	7.04	7.04	7.04	7.04	20
Other Noncurrent Operating Assets	140	127	120	114	101	91	96
Other Noncurrent Nonoperating Assets	1.85	1.05	1.08	1.08	1.14	1.21	1.24
Total Liabilities & Shareholders' Equity	1,296	1,265	1,281	1,282	1,320	1,340	1,563
Total Liabilities	414	385	394	395	393	392	576
Total Current Liabilities	210	183	198	205	206	217	248
Short-Term Debt	4.91	-	3.39	2.13	0.00	0.00	7.50
Accounts Payable	35	30	30	32	41	40	42
Accrued Expenses	77	57	67	70	64	82	90
Dividends Payable	8.77	8.73	9.04	9.04	9.09	9.41	9.42
Other Current Liabilities	84	88	88	92	85	85	100
Total Noncurrent Liabilities	204	202	197	190	187	175	328
Long-Term Debt	-	-	-	-	-	-	140
Asset Retirement Reserve & Litigation Obligation	73	74	75	77	77	78	79
Noncurrent Deferred & Payable Income Tax Liabilities	9.75	12	12	9.85	20	23	31
Other Noncurrent Operating Liabilities	119	117	109	103	90	73	78
Total Equity & Noncontrolling Interests	881	880	886	887	927	948	987
Total Preferred & Common Equity	877	877	884	885	925	946	983
Total Common Equity	877	877	884	885	925	946	983
Common Stock	229	225	226	227	227	230	231
Retained Earnings	659	660	667	668	705	722	756
Accumulated Other Comprehensive Income / (Loss)	-10	-7.85	-9.05	-10	-7.04	-5.91	-2.85
Noncontrolling Interest	4.02	2.80	2.44	2.17	1.77	2.03	3.33

This table displays calculated financial ratios and metrics derived from National HealthCare's official financial filings.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	10.49%	4.01%	1.87%	4.37%	1.71%	1.64%	3.20%	4.48%	1.06%	5.14%	14.53%
EBITDA Growth	-8.53%	2.35%	-2.58%	-1.70%	-0.36%	10.00%	-9.15%	-6.28%	-23.63%	38.67%	27.29%
EBIT Growth	-16.62%	0.10%	-5.94%	-7.05%	0.45%	14.90%	-13.20%	-8.01%	-37.35%	71.47%	42.90%
NOPAT Growth	-6.53%	-1.81%	-8.81%	5.95%	8.76%	-13.84%	1.84%	22.39%	-50.43%	79.65%	52.68%
Net Income Growth	-17.40%	-0.42%	-4.90%	10.18%	5.42%	15.80%	-38.23%	231.24%	-85.64%	226.82%	56.36%
EPS Growth	-18.86%	1.91%	3.75%	11.14%	4.88%	14.73%	-38.74%	230.51%	-83.87%	199.31%	50.46%
Operating Cash Flow Growth	-19.94%	1.73%	9.03%	3.94%	4.20%	1.69%	103.05%	-69.30%	-85.99%	1,172.20%	-3.52%
Free Cash Flow Firm Growth	-139.27%	128.21%	417.78%	147.57%	8.01%	-19.86%	272.85%	-187.90%	68.63%	283.60%	-283.80%
Invested Capital Growth	17.30%	10.03%	4.47%	-1.81%	-1.92%	-0.94%	-28.19%	61.64%	13.74%	-6.71%	40.82%
Revenue Q/Q Growth	2.30%	0.84%	0.11%	1.10%	0.35%	0.50%	29.08%	-15.83%	-1.71%	3.29%	5.52%
EBITDA Q/Q Growth	0.65%	1.08%	-1.97%	-0.83%	3.08%	1.09%	-18.92%	20.91%	-6.80%	34.99%	-5.48%
EBIT Q/Q Growth	-1.04%	1.03%	-3.50%	-2.42%	5.37%	1.41%	-26.42%	38.92%	-12.99%	63.75%	-7.23%
NOPAT Q/Q Growth	-1.67%	-0.67%	-2.69%	15.36%	-8.52%	-1.06%	-11.03%	-4.54%	-1.69%	26.54%	8.97%
Net Income Q/Q Growth	-4.55%	1.78%	-2.15%	15.41%	-5.11%	-6.14%	48.58%	-7.59%	-34.28%	52.20%	-17.69%
EPS Q/Q Growth	-3.38%	3.56%	-2.92%	15.67%	-5.15%	-6.33%	50.28%	-7.89%	-29.95%	49.14%	-18.27%
Operating Cash Flow Q/Q Growth	16.84%	-4.54%	7.16%	-2.71%	-2.09%	4.00%	-2.80%	-5.79%	-29.11%	14.16%	-10.76%
Free Cash Flow Firm Q/Q Growth	43.74%	-78.49%	83.08%	9.72%	12.31%	0.53%	-5.13%	-6.46%	7.11%	36.83%	-27.62%
Invested Capital Q/Q Growth	0.72%	4.03%	1.46%	1.75%	-0.58%	-0.73%	0.19%	1.39%	0.54%	-1.81%	3.92%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	41.46%	41.24%	40.66%	40.65%	40.56%	40.50%	39.61%	38.00%	36.80%	37.60%	37.97%
EBITDA Margin	13.72%	13.50%	12.91%	12.16%	11.91%	12.89%	11.35%	10.18%	7.69%	10.15%	11.28%
Operating Margin	7.80%	7.40%	6.56%	5.61%	5.72%	4.92%	4.68%	4.74%	2.94%	5.01%	6.56%
EBIT Margin	9.77%	9.41%	8.68%	7.73%	7.64%	8.64%	7.26%	6.39%	3.96%	6.46%	8.07%
Profit (Net Income) Margin	6.12%	5.86%	5.47%	5.78%	5.99%	6.82%	4.08%	12.95%	1.84%	5.72%	7.81%
Tax Burden Percent	62.64%	62.32%	63.01%	74.69%	78.39%	77.23%	80.10%	92.70%	73.36%	73.57%	74.84%
Interest Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	102.30%	70.20%	218.40%	63.27%	120.25%	129.36%
Effective Tax Rate	37.36%	37.68%	36.99%	25.31%	21.61%	22.77%	19.90%	7.30%	26.64%	26.43%	25.16%
Return on Invested Capital (ROIC)	12.12%	10.50%	8.94%	9.35%	10.36%	9.06%	10.79%	12.08%	4.53%	7.92%	10.40%
ROIC Less NNEP Spread (ROIC-NNEP)	9.13%	6.52%	3.39%	3.35%	5.36%	0.17%	10.00%	-7.79%	5.44%	1.51%	-1.10%
Return on Net Nonoperating Assets (RNNOA)	-4.62%	-2.71%	-1.17%	-1.24%	-2.20%	-0.08%	-5.47%	4.22%	-2.30%	-0.61%	0.38%
Return on Equity (ROE)	7.50%	7.79%	7.77%	8.11%	8.16%	8.98%	5.32%	16.30%	2.24%	7.30%	10.78%
Cash Return on Invested Capital (CROIC)	-3.80%	0.95%	4.57%	11.17%	12.30%	10.00%	43.60%	-35.04%	-8.32%	14.86%	-23.50%
Operating Return on Assets (OROA)	8.28%	8.05%	7.52%	6.83%	6.88%	7.27%	5.64%	4.97%	3.21%	5.71%	7.44%
Return on Assets (ROA)	5.19%	5.01%	4.74%	5.10%	5.39%	5.74%	3.17%	10.06%	1.49%	5.05%	7.20%
Return on Common Equity (ROCE)	5.71%	6.81%	7.77%	8.11%	8.15%	8.97%	5.31%	16.22%	2.23%	7.28%	10.76%
Return on Equity Simple (ROE_SIMPLE)	7.27%	8.42%	7.55%	7.92%	8.01%	8.73%	5.28%	15.40%	2.29%	7.18%	10.42%
Net Operating Profit after Tax (NOPAT)	43	42	38	40	44	38	39	47	23	42	64
NOPAT Margin	4.89%	4.61%	4.13%	4.19%	4.48%	3.80%	3.75%	4.39%	2.16%	3.68%	4.91%
Net Nonoperating Expense Percent (NNEP)	2.99%	3.98%	5.54%	6.00%	5.00%	8.89%	0.79%	19.87%	-0.91%	6.41%	11.50%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	2.65%	4.61%	5.73%
Cost of Revenue to Revenue	58.54%	58.76%	59.34%	59.35%	59.44%	59.50%	60.40%	62.00%	63.20%	62.40%	62.03%
SG&A Expenses to Revenue	24.91%	25.05%	24.99%	25.92%	25.91%	26.94%	26.76%	24.83%	26.65%	25.25%	24.58%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	33.66%	33.84%	34.11%	35.04%	34.84%	35.58%	34.92%	33.26%	33.86%	32.59%	31.41%
Earnings before Interest and Taxes (EBIT)	85	85	80	75	75	86	75	69	43	74	105
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	120	122	119	117	117	128	117	109	84	116	147
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	1.13	1.37	1.08	1.38	1.47	1.15	1.07	0.99	1.52	1.69
Price to Tangible Book Value (P/TBV)	0.00	1.17	1.41	1.11	1.42	1.52	1.18	1.33	1.23	1.89	2.10
Price to Revenue (P/Rev)	0.00	0.79	0.99	0.79	1.03	1.15	0.89	0.90	0.79	1.21	1.27
Price to Earnings (P/E)	0.00	15.44	18.14	13.54	17.13	16.83	21.81	6.97	38.40	20.73	16.29
Dividend Yield	2.81%	3.21%	2.89%	3.77%	2.99%	2.75%	3.50%	3.37%	4.02%	2.59%	2.25%
Earnings Yield	0.00%	6.48%	5.51%	7.39%	5.84%	5.94%	4.58%	14.34%	2.60%	4.82%	6.14%
Enterprise Value to Invested Capital (EV/IC)	0.00	1.19	1.56	1.12	1.65	1.87	1.37	1.12	0.96	1.91	1.93
Enterprise Value to Revenue (EV/Rev)	0.00	0.55	0.73	0.50	0.70	0.78	0.40	0.50	0.49	0.86	1.07
Enterprise Value to EBITDA (EV/EBITDA)	0.00	4.07	5.69	4.10	5.92	6.07	3.52	4.94	6.34	8.46	9.46
Enterprise Value to EBIT (EV/EBIT)	0.00	5.84	8.46	6.45	9.23	9.06	5.50	7.86	12.30	13.29	13.22
Enterprise Value to NOPAT (EV/NOPAT)	0.00	11.91	17.79	11.90	15.72	20.58	10.65	11.43	22.62	23.32	21.72
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	5.98	7.47	5.09	7.02	7.79	2.02	8.65	60.55	8.82	12.99
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	132.21	34.79	9.96	13.25	18.64	2.64	0.00	0.00	12.43	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.06	0.24	0.22	0.18	0.11	0.04	0.02	0.00	0.01	0.00	0.14
Long-Term Debt to Equity	0.06	0.24	0.22	0.17	0.10	0.02	0.01	0.00	0.00	0.00	0.13
Financial Leverage	-0.51	-0.42	-0.34	-0.37	-0.41	-0.45	-0.55	-0.54	-0.42	-0.41	-0.35
Leverage Ratio	1.45	1.55	1.64	1.59	1.51	1.56	1.68	1.62	1.50	1.45	1.50
Compound Leverage Factor	1.45	1.55	1.64	1.59	1.51	1.60	1.18	3.54	0.95	1.74	1.94
Debt to Total Capital	5.97%	19.57%	18.32%	15.27%	9.61%	3.60%	1.84%	0.00%	0.66%	0.09%	12.23%
Short-Term Debt to Total Capital	0.40%	0.42%	0.42%	0.45%	0.48%	1.75%	0.54%	0.00%	0.56%	0.09%	0.67%
Long-Term Debt to Total Capital	5.57%	19.15%	17.90%	14.82%	9.12%	1.85%	1.30%	0.00%	0.10%	0.00%	11.56%
Preferred Equity to Total Capital	21.84%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.08%	0.15%	0.06%	0.38%	0.60%	0.37%	0.19%	0.27%
Common Equity to Total Capital	72.19%	80.43%	81.68%	84.65%	90.25%	96.34%	97.78%	99.40%	98.97%	99.72%	87.50%
Debt to EBITDA	0.39	1.25	1.26	1.08	0.67	0.23	0.13	0.00	0.07	0.01	0.93
Net Debt to EBITDA	-2.99	-1.77	-2.00	-2.39	-2.74	-2.87	-4.33	0.00	-4.02	-3.50	-1.83
Long-Term Debt to EBITDA	0.36	1.23	1.23	1.05	0.63	0.12	0.09	0.00	0.01	0.00	0.88
Debt to NOPAT	1.09	3.67	3.94	3.14	1.78	0.77	0.39	0.00	0.25	0.02	2.13
Net Debt to NOPAT	-8.41	-5.19	-6.24	-6.94	-7.29	-9.75	-13.11	0.00	-14.35	-9.65	-4.20
Long-Term Debt to NOPAT	1.02	3.59	3.85	3.04	1.69	0.40	0.27	0.00	0.04	0.00	2.02
Altman Z-Score	0.00	2.81	3.07	2.99	3.74	3.09	2.64	2.91	3.13	4.04	3.77
Noncontrolling Interest Sharing Ratio	23.98%	12.49%	0.00%	0.05%	0.13%	0.11%	0.23%	0.50%	0.49%	0.28%	0.25%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.76	1.85	1.93	2.12	2.04	1.75	1.62	1.62	1.79	1.89	1.81
Quick Ratio	1.53	1.59	1.66	1.98	1.90	1.53	1.47	1.52	1.43	1.55	1.65
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-13	3.77	20	48	52	42	156	-137	-43	79	-145
Operating Cash Flow to CapEx	153.74%	142.69%	145.18%	292.04%	386.44%	379.18%	1,344.04%	158.36%	33.59%	398.61%	420.80%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.85	0.86	0.87	0.88	0.90	0.84	0.78	0.78	0.81	0.88	0.92
Accounts Receivable Turnover	10.99	11.13	11.09	11.39	10.65	10.47	11.26	11.56	11.07	10.95	10.72
Inventory Turnover	71.50	72.51	72.70	78.04	79.70	79.52	76.56	76.72	87.58	98.43	98.74
Fixed Asset Turnover	1.79	1.73	1.69	1.74	1.81	1.86	1.95	2.06	2.11	2.28	2.22
Accounts Payable Turnover	13.89	14.10	15.14	16.59	16.83	16.97	17.35	17.16	18.63	20.02	20.69
Days Sales Outstanding (DSO)	33.23	32.80	32.93	32.05	34.26	34.85	32.42	31.56	32.96	33.34	34.04
Days Inventory Outstanding (DIO)	5.11	5.03	5.02	4.68	4.58	4.59	4.77	4.76	4.17	3.71	3.70
Days Payable Outstanding (DPO)	26.28	25.90	24.11	22.01	21.68	21.51	21.04	21.28	19.59	18.23	17.65
Cash Conversion Cycle (CCC)	12.05	11.94	13.84	14.73	17.16	17.93	16.15	15.04	17.54	18.82	20.09
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	379	417	436	428	420	416	299	483	549	513	722
Invested Capital Turnover	2.48	2.28	2.16	2.23	2.31	2.38	2.88	2.75	2.10	2.15	2.12
Increase / (Decrease) in Invested Capital	56	38	19	-7.87	-8.20	-3.93	-117	184	66	-37	209
Enterprise Value (EV)	0.00	498	679	481	691	779	411	540	529	980	1,394
Market Capitalization	0.00	715	917	761	1,010	1,148	913	967	862	1,385	1,661
Book Value per Share	$40.80	$42.33	$44.20	$46.24	$48.14	$50.83	$51.77	$58.55	$56.98	$59.30	$63.48
Tangible Book Value per Share	$39.52	$41.15	$43.04	$45.08	$46.76	$49.46	$50.38	$47.18	$45.55	$47.86	$51.15
Total Capital	781	785	820	830	813	808	813	908	883	911	1,120
Total Debt	47	154	150	127	78	29	15	0.00	5.85	0.86	137
Total Long-Term Debt	44	150	147	123	74	15	11	0.00	0.86	0.00	130
Net Debt	-358	-217	-238	-281	-320	-369	-506	-432	-336	-406	-270
Capital Expenditures (CapEx)	53	58	63	32	25	26	15	39	26	28	26
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-87	-50	-47	-48	-44	-72	-174	-151	-75	-88	-73
Debt-free Net Working Capital (DFNWC)	142	132	143	178	168	160	180	163	161	193	197
Net Working Capital (NWC)	139	128	140	174	164	146	176	163	156	192	190
Net Nonoperating Expense (NNE)	-11	-11	-12	-15	-15	-30	-3.42	-92	3.42	-23	-38
Net Nonoperating Obligations (NNO)	-355	-214	-234	-275	-314	-363	-499	-425	-328	-398	-261
Total Depreciation and Amortization (D&A)	34	37	39	43	42	42	42	41	40	42	42
Debt-free, Cash-free Net Working Capital to Revenue	-9.99%	-5.50%	-5.07%	-4.95%	-4.50%	-7.21%	-16.97%	-14.03%	-6.93%	-7.74%	-5.61%
Debt-free Net Working Capital to Revenue	16.30%	14.51%	15.53%	18.46%	17.14%	16.10%	17.50%	15.21%	14.83%	16.87%	15.08%
Net Working Capital to Revenue	15.94%	14.15%	15.15%	18.08%	16.74%	14.68%	17.07%	15.21%	14.37%	16.80%	14.50%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$3.24	$3.34	$3.34	$3.70	$3.87	$4.47	$2.74	$9.03	$1.46	$4.36	$6.62
Adjusted Weighted Average Basic Shares Outstanding	13.82M	13.89M	15.13M	15.19M	15.22M	15.27M	15.31M	15.35M	15.41M	15.31M	15.39M
Adjusted Diluted Earnings per Share	$3.14	$3.20	$3.32	$3.69	$3.87	$4.44	$2.72	$8.99	$1.45	$4.34	$6.53
Adjusted Weighted Average Diluted Shares Outstanding	14.22M	14.49M	15.21M	15.22M	15.24M	15.36M	15.37M	15.42M	15.45M	15.38M	15.60M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	14.11M	15.01M	15.18M	15.22M	15.26M	15.33M	15.37M	15.45M	15.36M	15.35M	15.45M
Normalized Net Operating Profit after Tax (NOPAT)	43	42	38	40	44	38	39	55	23	42	64
Normalized NOPAT Margin	4.89%	4.61%	4.13%	4.19%	4.48%	3.80%	3.75%	5.10%	2.16%	3.68%	4.91%
Pre Tax Income Margin	9.77%	9.41%	8.68%	7.73%	7.64%	8.83%	5.10%	13.97%	2.51%	7.77%	10.43%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	51.29%	56.59%	51.04%	50.71%	50.81%	46.60%	70.10%	23.72%	171.97%	54.47%	35.12%
Augmented Payout Ratio	64.40%	56.59%	67.26%	50.71%	52.29%	47.88%	70.22%	24.32%	221.54%	58.27%	48.34%

This table displays calculated financial ratios and metrics derived from National HealthCare's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-2.13%	-6.66%	-3.38%	4.14%	6.51%	13.74%	10.24%	6.40%	17.93%	22.74%
EBITDA Growth	-35.35%	-21.53%	-10.27%	62.57%	59.75%	63.98%	30.83%	32.63%	31.67%	17.56%
EBIT Growth	-57.87%	-35.37%	-17.69%	149.90%	151.46%	110.09%	48.69%	55.47%	47.59%	27.27%
NOPAT Growth	-68.05%	-2.13%	-32.35%	257.00%	229.18%	125.51%	59.85%	67.35%	64.79%	72.30%
Net Income Growth	12.38%	-65.15%	-26.48%	636.56%	425.75%	401.70%	132.62%	70.30%	321.90%	-78.44%
EPS Growth	27.27%	-60.19%	-23.23%	404.76%	525.00%	348.78%	122.37%	63.21%	301.47%	-79.35%
Operating Cash Flow Growth	-129.29%	-23.12%	150.47%	49.84%	1,734.04%	115.63%	-30.39%	28.84%	5.89%	-50.30%
Free Cash Flow Firm Growth	60.28%	66.40%	101.98%	108.03%	150.35%	187.64%	695.63%	751.14%	-564.09%	-450.07%
Invested Capital Growth	14.71%	13.74%	0.45%	0.68%	-4.47%	-6.71%	-4.79%	-7.02%	33.05%	40.82%
Revenue Q/Q Growth	-0.19%	-2.32%	1.89%	4.83%	2.09%	4.31%	-1.24%	1.17%	13.15%	8.57%
EBITDA Q/Q Growth	-0.06%	30.22%	280.27%	13.83%	-1.80%	33.66%	-37.91%	15.40%	-2.51%	19.34%
EBIT Q/Q Growth	-3.72%	72.42%	452.56%	23.29%	-3.12%	44.05%	-46.19%	28.91%	-8.03%	24.21%
NOPAT Q/Q Growth	2.26%	138.38%	5.61%	38.67%	-5.71%	63.31%	-25.14%	45.18%	-7.16%	70.76%
Net Income Q/Q Growth	-243.78%	279.40%	102.46%	41.05%	-36.41%	176.31%	-6.13%	3.26%	57.53%	-85.88%
EPS Q/Q Growth	-176.19%	356.25%	85.37%	39.47%	-35.85%	170.59%	-8.15%	2.37%	57.80%	-86.08%
Operating Cash Flow Q/Q Growth	-107.53%	703.64%	16.11%	183.76%	-17.84%	-20.34%	-62.52%	425.20%	-32.48%	-62.61%
Free Cash Flow Firm Q/Q Growth	15.24%	11.37%	107.95%	34.51%	431.30%	54.27%	-27.84%	43.90%	-389.70%	-16.37%
Invested Capital Q/Q Growth	2.96%	0.54%	-0.45%	-2.31%	-2.31%	-1.81%	1.60%	-4.60%	39.80%	3.92%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	36.05%	36.75%	37.74%	37.97%	36.68%	38.00%	38.37%	40.11%	37.27%	36.56%
EBITDA Margin	6.30%	8.40%	9.05%	9.82%	9.45%	12.11%	10.73%	12.24%	10.55%	11.60%
Operating Margin	1.51%	3.42%	3.71%	4.95%	4.52%	6.69%	5.26%	7.49%	6.19%	7.19%
EBIT Margin	2.51%	4.44%	5.32%	6.25%	5.94%	8.20%	7.17%	9.14%	7.43%	8.50%
Profit (Net Income) Margin	-1.15%	2.11%	4.19%	5.63%	3.51%	9.29%	8.83%	9.02%	12.55%	1.63%
Tax Burden Percent	73.16%	75.19%	71.78%	71.30%	72.14%	76.27%	73.51%	74.06%	73.57%	99.54%
Interest Burden Percent	-62.37%	63.14%	109.67%	126.31%	81.94%	148.66%	167.56%	133.21%	229.66%	19.30%
Effective Tax Rate	0.00%	24.81%	28.22%	28.70%	27.86%	23.73%	26.49%	25.94%	26.43%	0.46%
Return on Invested Capital (ROIC)	2.28%	5.41%	5.26%	7.20%	6.74%	10.96%	8.47%	12.77%	9.27%	15.17%
ROIC Less NNEP Spread (ROIC-NNEP)	3.84%	5.74%	4.09%	5.56%	6.53%	7.49%	4.47%	10.18%	0.99%	21.36%
Return on Net Nonoperating Assets (RNNOA)	-1.64%	-2.42%	-1.60%	-2.25%	-2.59%	-3.04%	-1.83%	-4.46%	-0.35%	-7.44%
Return on Equity (ROE)	0.64%	2.99%	3.66%	4.95%	4.15%	7.92%	6.64%	8.32%	8.92%	7.73%
Cash Return on Invested Capital (CROIC)	-9.05%	-8.32%	3.15%	4.34%	10.79%	14.86%	13.58%	17.56%	-18.68%	-23.50%
Operating Return on Assets (OROA)	2.05%	3.60%	4.37%	5.17%	5.09%	7.24%	6.49%	8.28%	6.47%	7.84%
Return on Assets (ROA)	-0.93%	1.71%	3.44%	4.66%	3.01%	8.20%	7.99%	8.17%	10.93%	1.51%
Return on Common Equity (ROCE)	0.63%	2.98%	3.64%	4.93%	4.14%	7.90%	6.62%	8.30%	8.90%	7.71%
Return on Equity Simple (ROE_SIMPLE)	3.46%	0.00%	1.81%	3.36%	4.85%	0.00%	8.68%	9.67%	12.61%	0.00%
Net Operating Profit after Tax (NOPAT)	2.85	6.80	7.19	9.97	9.40	15	11	17	15	26
NOPAT Margin	1.05%	2.57%	2.67%	3.53%	3.26%	5.10%	3.87%	5.55%	4.55%	7.16%
Net Nonoperating Expense Percent (NNEP)	-1.57%	-0.33%	1.17%	1.64%	0.21%	3.48%	4.00%	2.60%	8.28%	-6.19%
Return On Investment Capital (ROIC_SIMPLE)	-	0.77%	-	-	-	1.68%	-	-	-	2.36%
Cost of Revenue to Revenue	63.95%	63.25%	62.26%	62.03%	63.32%	62.00%	61.63%	59.89%	62.73%	63.44%
SG&A Expenses to Revenue	26.91%	26.87%	26.52%	25.92%	25.13%	23.58%	26.05%	25.99%	24.25%	22.55%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	34.55%	33.32%	34.03%	33.02%	32.17%	31.32%	33.11%	32.62%	31.09%	29.37%
Earnings before Interest and Taxes (EBIT)	6.81	12	14	18	17	25	21	27	25	31
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	17	22	24	28	27	36	32	37	36	43
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.06	0.99	0.98	1.04	1.08	1.52	1.56	1.77	1.97	1.69
Price to Tangible Book Value (P/TBV)	1.32	1.23	1.22	1.30	1.35	1.89	1.92	2.17	2.44	2.10
Price to Revenue (P/Rev)	0.84	0.79	0.80	0.85	0.87	1.21	1.23	1.41	1.57	1.27
Price to Earnings (P/E)	29.08	38.40	45.58	28.86	21.40	20.73	17.72	18.17	15.61	16.29
Dividend Yield	3.74%	4.02%	4.07%	3.82%	3.71%	2.59%	2.51%	2.20%	1.91%	2.25%
Earnings Yield	3.44%	2.60%	2.19%	3.47%	4.67%	4.82%	5.64%	5.50%	6.41%	6.14%
Enterprise Value to Invested Capital (EV/IC)	1.08	0.96	0.95	1.06	1.12	1.91	1.97	2.44	2.37	1.93
Enterprise Value to Revenue (EV/Rev)	0.53	0.49	0.48	0.52	0.53	0.86	0.88	1.02	1.33	1.07
Enterprise Value to EBITDA (EV/EBITDA)	6.58	6.34	8.03	7.46	6.84	8.46	7.43	8.23	10.53	9.46
Enterprise Value to EBIT (EV/EBIT)	11.92	12.30	21.59	16.23	13.02	13.29	10.74	11.49	14.45	13.22
Enterprise Value to NOPAT (EV/NOPAT)	24.76	22.62	26.52	21.10	17.66	23.32	22.20	22.87	27.89	21.72
Enterprise Value to Operating Cash Flow (EV/OCF)	47.79	60.55	10.42	8.93	6.02	8.82	9.61	10.24	13.66	12.99
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	30.29	24.38	10.17	12.43	14.18	13.39	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.15	0.14
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.14	0.13
Financial Leverage	-0.43	-0.42	-0.39	-0.40	-0.40	-0.41	-0.41	-0.44	-0.35	-0.35
Leverage Ratio	1.52	1.50	1.46	1.47	1.46	1.45	1.43	1.43	1.52	1.50
Compound Leverage Factor	-0.95	0.95	1.61	1.86	1.19	2.15	2.40	1.90	3.49	0.29
Debt to Total Capital	0.79%	0.66%	0.00%	0.38%	0.24%	0.09%	0.00%	0.00%	12.97%	12.23%
Short-Term Debt to Total Capital	0.55%	0.56%	0.00%	0.38%	0.24%	0.09%	0.00%	0.00%	0.66%	0.67%
Long-Term Debt to Total Capital	0.24%	0.10%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	12.30%	11.56%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.45%	0.37%	0.32%	0.27%	0.24%	0.19%	0.19%	0.21%	0.29%	0.27%
Common Equity to Total Capital	98.75%	98.97%	99.68%	99.35%	99.52%	99.72%	99.81%	99.79%	86.74%	87.50%
Debt to EBITDA	0.08	0.07	0.00	0.04	0.02	0.01	0.00	0.00	0.94	0.93
Net Debt to EBITDA	-3.81	-4.02	0.00	-4.76	-4.35	-3.50	0.00	0.00	-1.93	-1.83
Long-Term Debt to EBITDA	0.02	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.89	0.88
Debt to NOPAT	0.30	0.25	0.00	0.13	0.06	0.02	0.00	0.00	2.50	2.13
Net Debt to NOPAT	-14.36	-14.35	0.00	-13.47	-11.24	-9.65	0.00	0.00	-5.10	-4.20
Long-Term Debt to NOPAT	0.09	0.04	0.00	0.00	0.00	0.00	0.00	0.00	2.37	2.02
Altman Z-Score	3.05	3.05	3.10	3.19	3.26	3.92	4.08	4.47	3.70	3.61
Noncontrolling Interest Sharing Ratio	0.57%	0.49%	0.48%	0.40%	0.35%	0.28%	0.25%	0.24%	0.29%	0.25%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.64	1.79	1.84	1.86	1.87	1.89	2.02	2.06	1.80	1.81
Quick Ratio	1.31	1.43	1.59	1.49	1.53	1.55	1.66	1.75	1.53	1.65
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-67	-60	4.73	6.37	34	52	38	54	-157	-183
Operating Cash Flow to CapEx	-26.26%	211.71%	208.69%	639.47%	496.16%	299.19%	161.98%	646.76%	604.79%	156.80%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.81	0.81	0.82	0.83	0.86	0.88	0.90	0.91	0.87	0.92
Accounts Receivable Turnover	11.16	11.07	10.51	10.79	10.96	10.95	10.22	11.27	10.71	10.72
Inventory Turnover	87.74	87.58	87.99	95.23	94.49	98.43	106.16	107.50	100.33	98.74
Fixed Asset Turnover	2.14	2.11	2.10	2.14	2.19	2.28	2.36	2.40	2.09	2.22
Accounts Payable Turnover	16.53	18.63	18.78	18.39	20.69	20.02	20.70	20.87	20.74	20.69
Days Sales Outstanding (DSO)	32.72	32.96	34.74	33.84	33.29	33.34	35.71	32.38	34.08	34.04
Days Inventory Outstanding (DIO)	4.16	4.17	4.15	3.83	3.86	3.71	3.44	3.40	3.64	3.70
Days Payable Outstanding (DPO)	22.08	19.59	19.44	19.84	17.64	18.23	17.63	17.49	17.60	17.65
Cash Conversion Cycle (CCC)	14.80	17.54	19.45	17.83	19.51	18.82	21.52	18.29	20.12	20.09
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	546	549	547	534	522	513	521	497	695	722
Invested Capital Turnover	2.16	2.10	1.97	2.04	2.07	2.15	2.19	2.30	2.04	2.12
Increase / (Decrease) in Invested Capital	70	66	2.45	3.60	-24	-37	-26	-38	173	209
Enterprise Value (EV)	589	529	521	564	587	980	1,028	1,212	1,643	1,394
Market Capitalization	927	862	859	921	958	1,385	1,440	1,669	1,940	1,661
Book Value per Share	$56.65	$56.98	$57.12	$57.70	$57.78	$59.30	$60.24	$61.42	$63.76	$63.48
Tangible Book Value per Share	$45.32	$45.55	$45.70	$46.25	$46.33	$47.86	$48.82	$50.03	$51.48	$51.15
Total Capital	888	883	880	890	889	911	927	948	1,134	1,120
Total Debt	7.05	5.85	0.00	3.39	2.13	0.86	0.00	0.00	147	137
Total Long-Term Debt	2.13	0.86	0.00	0.00	0.00	0.00	0.00	0.00	140	130
Net Debt	-342	-336	-341	-360	-373	-406	-414	-459	-300	-270
Capital Expenditures (CapEx)	7.53	5.64	6.64	6.15	6.51	8.60	5.96	7.83	5.66	8.16
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-89	-75	-65	-76	-85	-88	-67	-91	-98	-73
Debt-free Net Working Capital (DFNWC)	139	161	155	174	180	193	211	231	205	197
Net Working Capital (NWC)	134	156	155	171	178	192	211	231	198	190
Net Nonoperating Expense (NNE)	5.96	1.23	-4.10	-5.95	-0.72	-13	-15	-10	-27	20
Net Nonoperating Obligations (NNO)	-335	-328	-333	-352	-365	-398	-406	-451	-292	-261
Total Depreciation and Amortization (D&A)	10	10	10	10	10	12	11	9.34	11	11
Debt-free, Cash-free Net Working Capital to Revenue	-8.02%	-6.93%	-6.03%	-6.95%	-7.69%	-7.74%	-5.71%	-7.70%	-7.94%	-5.61%
Debt-free Net Working Capital to Revenue	12.61%	14.83%	14.37%	16.03%	16.29%	16.87%	18.06%	19.45%	16.57%	15.08%
Net Working Capital to Revenue	12.16%	14.37%	14.37%	15.72%	16.10%	16.80%	18.06%	19.45%	15.96%	14.50%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.16)	$0.42	$0.76	$1.06	$0.68	$1.86	$1.71	$1.74	$2.78	$0.39
Adjusted Weighted Average Basic Shares Outstanding	15.45M	15.41M	15.34M	15.30M	15.30M	15.31M	15.35M	15.39M	15.41M	15.39M
Adjusted Diluted Earnings per Share	($0.16)	$0.41	$0.76	$1.06	$0.68	$1.84	$1.69	$1.73	$2.73	$0.38
Adjusted Weighted Average Diluted Shares Outstanding	15.45M	15.45M	15.36M	15.32M	15.32M	15.38M	15.51M	15.56M	15.67M	15.60M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	15.34M	15.36M	15.32M	15.32M	15.32M	15.35M	15.40M	15.42M	15.44M	15.45M
Normalized Net Operating Profit after Tax (NOPAT)	2.85	6.80	7.19	9.97	9.40	15	11	17	15	26
Normalized NOPAT Margin	1.05%	2.57%	2.67%	3.53%	3.26%	5.10%	3.87%	5.55%	4.55%	7.16%
Pre Tax Income Margin	-1.57%	2.80%	5.83%	7.90%	4.86%	12.18%	12.02%	12.17%	17.06%	1.64%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	113.70%	171.97%	219.06%	118.25%	82.28%	54.47%	44.69%	39.61%	28.38%	35.12%
Augmented Payout Ratio	138.26%	221.54%	295.97%	159.50%	95.05%	58.27%	57.02%	52.07%	39.27%	48.34%

Frequently Asked Questions About National HealthCare's Financials

When does National HealthCare's fiscal year end?

According to the most recent income statement we have on file, National HealthCare's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has National HealthCare's net income changed over the last 10 years?

National HealthCare's net income appears to be on an upward trend, with a most recent value of $102.09 million in 2024, rising from $53.37 million in 2014. The previous period was $65.29 million in 2023.

What is National HealthCare's operating income?

National HealthCare's total operating income in 2024 was $85.76 million, based on the following breakdown:

Total Gross Profit: $496.45 million
Total Operating Expenses: $410.69 million

How has National HealthCare revenue changed over the last 10 years?

Over the last 10 years, National HealthCare's total revenue changed from $871.68 million in 2014 to $1.31 billion in 2024, a change of 50.0%.

How much debt does National HealthCare have?

National HealthCare's total liabilities were at $541.27 million at the end of 2024, a 35.2% increase from 2023, and a 59.2% increase since 2014.

How much cash does National HealthCare have?

In the past 10 years, National HealthCare's cash and equivalents has ranged from $26.34 million in 2016 to $147.09 million in 2020, and is currently $76.12 million as of their latest financial filing in 2024.

How has National HealthCare's book value per share changed over the last 10 years?

Over the last 10 years, National HealthCare's book value per share changed from 40.80 in 2014 to 63.48 in 2024, a change of 55.6%.

Related Companies

This page (NYSEAMERICAN:NHC) was last updated on 5/4/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

National HealthCare (NHC) Financials

Frequently Asked Questions About National HealthCare's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

National HealthCare (NHC) Financials

Annual Income Statements for National HealthCare

Quarterly Income Statements for National HealthCare

Annual Cash Flow Statements for National HealthCare

Quarterly Cash Flow Statements for National HealthCare

Annual Balance Sheets for National HealthCare

Quarterly Balance Sheets for National HealthCare

Annual Metrics and Ratios for National HealthCare

Quarterly Metrics and Ratios for National HealthCare

Frequently Asked Questions About National HealthCare's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools